Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020
- PMID: 35406377
- PMCID: PMC8996850
- DOI: 10.3390/cancers14071605
Divergent Patterns in Care Utilization and Financial Distress between Patients with Blood Cancers and Solid Tumors: A National Health Interview Survey Study, 2014-2020
Abstract
Introduction: Important differences exist between the presentation, treatment, and survivorship of patients and survivors with blood cancers. Furthermore, existing research in financial toxicity has not fully addressed the relationship between medical care utilization and patient-reported outcomes of financial barriers and distress. We answered these questions by using a nationally representative survey. Methods: Respondents with blood cancers and solid tumors from the National Health Interview Survey were identified (2014−2020). We identified 23 survey questions as study outcomes and grouped them into three domains of medical care utilization, financial barriers to care, and financial distress. Associations between the three domains and associations of study outcomes between cancer types were examined using weighted univariate analyses and multivariable linear and logistic regressions. Results: The final study group consisted of 6248 respondents with solid tumors and 398 with blood cancers (diagnosed ≤ 5 years). Across all respondents with cancer, higher medical care utilization is generally associated with increased financial barriers to care. Compared to respondents with solid tumors, respondents with blood cancers had a higher level of medical care utilization (β = 0.36, p = 0.02), a lower level of financial barriers to care (β = −0.19, p < 0.0001), and a higher level of financial distress in affording care (β = 0.64, p = 0.03). Conclusions: Patients and survivors with blood cancers and solid tumors demonstrate divergent patterns in care utilization, financial barriers, and financial distress. Future research and interventions on financial toxicity should be tailored for individual cancer groups, recognizing the differences in medical care utilization, which affect the experienced financial barriers.
Keywords: financial hardship; financial stress; health services accessibility; health services research; healthcare surveys; hematologic neoplasms; medical oncology.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Association of Health Insurance Literacy With Financial Hardship in Patients With Cancer.JAMA Netw Open. 2022 Jul 1;5(7):e2223141. doi: 10.1001/jamanetworkopen.2022.23141. JAMA Netw Open. 2022. PMID: 35877122 Free PMC article.
-
Financial worry and psychological distress among cancer survivors in the United States, 2013-2018.Support Care Cancer. 2021 Sep;29(9):5523-5535. doi: 10.1007/s00520-021-06084-1. Epub 2021 Mar 16. Support Care Cancer. 2021. PMID: 33725174
-
Impact of Health Care-Associated Cost Concerns on Mammography Utilization: Cross-Sectional Survey Results From the National Health Interview Survey.J Am Coll Radiol. 2022 Oct;19(10):1081-1087. doi: 10.1016/j.jacr.2022.06.001. Epub 2022 Jul 22. J Am Coll Radiol. 2022. PMID: 35879187
-
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States.J Natl Cancer Inst. 2021 Aug 2;113(8):997-1004. doi: 10.1093/jnci/djab013. J Natl Cancer Inst. 2021. PMID: 33839786 Free PMC article.
-
Financial Hardship and the Economic Effect of Childhood Cancer Survivorship.J Clin Oncol. 2018 Jul 20;36(21):2198-2205. doi: 10.1200/JCO.2017.76.4431. Epub 2018 Jun 6. J Clin Oncol. 2018. PMID: 29874136 Review.
Cited by
-
Social Needs in Cancer Survivors: A Scoping Review and Future Directions.Curr Oncol Rep. 2025 Jun;27(6):717-733. doi: 10.1007/s11912-025-01664-4. Epub 2025 May 5. Curr Oncol Rep. 2025. PMID: 40323567
-
Financial Toxicity Interventions in Hematologic Malignancies Are Timely and Necessary.JCO Oncol Pract. 2022 Sep;18(9):607-609. doi: 10.1200/OP.22.00357. Epub 2022 Jul 8. JCO Oncol Pract. 2022. PMID: 35802841 Free PMC article. No abstract available.
-
Addressing financial hardship in malignant hematology and hematopoietic cell transplant: a team approach.Blood Adv. 2024 Oct 8;8(19):5146-5155. doi: 10.1182/bloodadvances.2024012998. Blood Adv. 2024. PMID: 39146495 Free PMC article.
-
"Somewhat of an Adult": Understanding the "Dance" of Competing Tensions Parents Manage While Caring for an Adolescent or Young Adult (AYA) Diagnosed with Hematologic Malignancy.Cancers (Basel). 2025 Apr 12;17(8):1299. doi: 10.3390/cancers17081299. Cancers (Basel). 2025. PMID: 40282475 Free PMC article.
-
Financial Toxicity, Time Toxicity, and Quality of Life in Multiple Myeloma.Clin Lymphoma Myeloma Leuk. 2024 Jul;24(7):446-454.e3. doi: 10.1016/j.clml.2024.02.013. Epub 2024 Feb 23. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38521640 Free PMC article.
References
-
- De Souza J.A., Yap B.J., Wroblewski K., Blinder V., Araújo F.S., Hlubocky F.J., Nicholas L.H., O’Connor J.M., Brockstein B., Ratain M.J., et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST) Cancer. 2017;123:476–484. doi: 10.1002/cncr.30369. - DOI - PMC - PubMed
-
- Zafar S.Y., Peppercorn J.M., Schrag D., Taylor D.H., Goetzinger A.M., Zhong X., Abernethy A.P. The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient’s experience. Oncologist. 2013;18:381–390. doi: 10.1634/theoncologist.2012-0279. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources